4

FORM 4 SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: January 11, 2023
Period of Report: January 9, 2023
Accession Number: 0000899243-23-001626

View Document ↗ View on SEC.gov ↗